Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion type Assertion NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_head.
- NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_provenance.
- NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion evidence source_evidence_literature NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_provenance.
- NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion SIO_000772 19434073 NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_provenance.
- NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion wasDerivedFrom befree-20140225 NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_provenance.
- NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_assertion wasGeneratedBy ECO_0000203 NP247377.RApqP8c7AqfUjSYd-jJoDoIK5AkvwG9iC-Ltkht33xZ3c130_provenance.